Stock Scorecard
Stock Summary for Icon Plc (ICLR) - $300.08 as of 4/26/2024 3:21:25 PM EST
Total Score
7 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ICLR
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ICLR
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ICLR
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for ICLR
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for ICLR
Financial Details for ICLR
Company Overview |
|
---|---|
Ticker | ICLR |
Company Name | Icon Plc |
Country | USA |
Description | ICON Public Limited Company, a clinical research organization, provides outsourced marketing and development services in Ireland, the rest of Europe, the United States and internationally. The company is headquartered in Dublin, Ireland. |
Sector Name | TRADE & SERVICES |
Industry Name | SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 7/23/2024 |
Stock Price History |
|
Last Day Price | 300.08 |
Last Day Price Updated | 4/26/2024 3:21:25 PM EST |
Last Day Volume | 0 |
Average Daily Volume | 495,783 |
52-Week High | 344.77 |
52-Week Low | 181.92 |
Last Price to 52 Week Low | 64.95% |
Valuation Measures |
|
Trailing PE | 41.82 |
Industry PE | 31.76 |
Sector PE | 39.76 |
5-Year Average PE | 39.60 |
Free Cash Flow Ratio | 62.52 |
Industry Free Cash Flow Ratio | 41.88 |
Sector Free Cash Flow Ratio | 87.16 |
Current Ratio Most Recent Quarter | 1.21 |
Total Cash Per Share | 4.80 |
Book Value Per Share Most Recent Quarter | 112.02 |
Price to Book Ratio | 2.73 |
Industry Price to Book Ratio | 8.15 |
Sector Price to Book Ratio | 8.79 |
Price to Sales Ratio Twelve Trailing Months | 3.11 |
Industry Price to Sales Ratio Twelve Trailing Months | 4.00 |
Sector Price to Sales Ratio Twelve Trailing Months | 1.87 |
Share Statistics |
|
Total Shares Outstanding | 82,495,000 |
Market Capitalization | 24,755,099,600 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 81.60% |
Annual Earnings Growth | 21.18% |
Reported EPS 12 Trailing Months | 7.40 |
Reported EPS Past Year | 3.47 |
Reported EPS Prior Year | 12.77 |
Net Income Twelve Trailing Months | 683,119,000 |
Net Income Past Year | 612,335,000 |
Net Income Prior Year | 505,304,000 |
Quarterly Revenue Growth YOY | 5.30% |
5-Year Revenue Growth | 25.62% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 396,082,000 |
Total Cash Past Year | 378,102,000 |
Total Cash Prior Year | 288,768,000 |
Net Cash Position Most Recent Quarter | -3,269,357,000 |
Net Cash Position Past Year | -3,287,337,000 |
Long Term Debt Past Year | 3,665,439,000 |
Long Term Debt Prior Year | 4,599,037,000 |
Total Debt Most Recent Quarter | 3,665,439,000 |
Equity to Debt Ratio Past Year | 0.72 |
Equity to Debt Ratio Most Recent Quarter | 0.72 |
Total Stockholder Equity Past Year | 9,240,743,000 |
Total Stockholder Equity Prior Year | 8,497,963,000 |
Total Stockholder Equity Most Recent Quarter | 9,432,647,000 |
Options |
|
Put/Call Ratio | 19.27 |
Has Options | Options Chain |
Liquidity Rating | None |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -5.11 |
MACD Signal | -4.82 |
20-Day Bollinger Lower Band | 241.58 |
20-Day Bollinger Middle Band | 295.64 |
20-Day Bollinger Upper Band | 349.69 |
Beta | 1.16 |
RSI | 51.25 |
50-Day SMA | 263.74 |
200-Day SMA | 230.72 |
System |
|
Modified | 4/27/2024 3:01:06 AM EST |